UDEMY INC (UDMY)

US9026851066 - Common Stock

8.23  0 (0%)

Fundamental Rating

4

UDMY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 70 industry peers in the Diversified Consumer Services industry. The financial health of UDMY is average, but there are quite some concerns on its profitability. UDMY has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year UDMY was profitable.
In the past year UDMY had a positive cash flow from operations.
UDMY had negative earnings in each of the past 5 years.
UDMY had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -15.71%, UDMY is doing worse than 69.84% of the companies in the same industry.
UDMY has a worse Return On Equity (-48.75%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -15.71%
ROE -48.75%
ROIC N/A
ROA(3y)-15.38%
ROA(5y)-26.62%
ROE(3y)-31.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UDMY has a better Gross Margin (61.14%) than 73.02% of its industry peers.
UDMY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for UDMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.88%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

UDMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
UDMY has more shares outstanding than it did 1 year ago.
There is no outstanding debt for UDMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

UDMY has an Altman-Z score of 0.90. This is a bad value and indicates that UDMY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, UDMY is in line with its industry, outperforming 50.79% of the companies in the same industry.
UDMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.9
ROIC/WACCN/A
WACC9.22%

2.3 Liquidity

UDMY has a Current Ratio of 1.26. This is a normal value and indicates that UDMY is financially healthy and should not expect problems in meeting its short term obligations.
UDMY has a Current ratio (1.26) which is in line with its industry peers.
UDMY has a Quick Ratio of 1.26. This is a normal value and indicates that UDMY is financially healthy and should not expect problems in meeting its short term obligations.
UDMY has a Quick ratio (1.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26

6

3. Growth

3.1 Past

UDMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 144.44%, which is quite impressive.
UDMY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.16%.
UDMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.25% yearly.
EPS 1Y (TTM)144.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)10.16%
Revenue growth 3Y19.25%
Revenue growth 5YN/A
Sales Q2Q%5.79%

3.2 Future

Based on estimates for the next years, UDMY will show a very strong growth in Earnings Per Share. The EPS will grow by 45570700.00% on average per year.
UDMY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.01% yearly.
EPS Next Y1706640880231900400%
EPS Next 2Y23337217113.23%
EPS Next 3Y45570700%
EPS Next 5YN/A
Revenue Next Year7.71%
Revenue Next 2Y5.52%
Revenue Next 3Y6.38%
Revenue Next 5Y9.01%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 102.88 indicates a quite expensive valuation of UDMY.
UDMY's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of UDMY to the average of the S&P500 Index (27.17), we can say UDMY is valued expensively.
A Price/Forward Earnings ratio of 21.78 indicates a rather expensive valuation of UDMY.
Based on the Price/Forward Earnings ratio, UDMY is valued a bit cheaper than 60.32% of the companies in the same industry.
UDMY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.59.
Industry RankSector Rank
PE 102.88
Fwd PE 21.78

4.2 Price Multiples

UDMY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.78
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UDMY's earnings are expected to grow with 45570700.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y23337217113.23%
EPS Next 3Y45570700%

0

5. Dividend

5.1 Amount

UDMY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UDEMY INC

NASDAQ:UDMY (1/2/2025, 3:15:42 PM)

8.23

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)N/A N/A
Inst Owners85.04%
Inst Owner Change-2.44%
Ins Owners3.21%
Ins Owner Change-3.61%
Market Cap1.20B
Analysts78.95
Price Target11.38 (38.27%)
Short Float %4.85%
Short Ratio9.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)112.06%
Min EPS beat(2)-262.44%
Max EPS beat(2)486.56%
EPS beat(4)3
Avg EPS beat(4)193.04%
Min EPS beat(4)-262.44%
Max EPS beat(4)486.56%
EPS beat(8)7
Avg EPS beat(8)163.17%
EPS beat(12)10
Avg EPS beat(12)116.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)-0.56%
Revenue beat(4)0
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)-0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.27%
Revenue beat(12)6
Avg Revenue beat(12)-0.05%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.86%
PT rev (3m)-7.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)162.2%
EPS NY rev (1m)0%
EPS NY rev (3m)346.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 102.88
Fwd PE 21.78
P/S 1.55
P/FCF 55.78
P/OCF 33.17
P/B 6.12
P/tB 8.13
EV/EBITDA N/A
EPS(TTM)0.08
EY0.97%
EPS(NY)0.38
Fwd EY4.59%
FCF(TTM)0.15
FCFY1.79%
OCF(TTM)0.25
OCFY3.01%
SpS5.32
BVpS1.35
TBVpS1.01
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.71%
ROE -48.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.14%
FCFM 2.77%
ROA(3y)-15.38%
ROA(5y)-26.62%
ROE(3y)-31.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.88%
GM growth 5YN/A
F-Score7
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 56.35%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 0.9
F-Score7
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)82.06%
Cap/Depr(5y)100.97%
Cap/Sales(3y)2.61%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y1706640880231900400%
EPS Next 2Y23337217113.23%
EPS Next 3Y45570700%
EPS Next 5YN/A
Revenue 1Y (TTM)10.16%
Revenue growth 3Y19.25%
Revenue growth 5YN/A
Sales Q2Q%5.79%
Revenue Next Year7.71%
Revenue Next 2Y5.52%
Revenue Next 3Y6.38%
Revenue Next 5Y9.01%
EBIT growth 1Y34.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year322.79%
EBIT Next 3Y115.66%
EBIT Next 5Y74.65%
FCF growth 1Y149.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y229.5%
OCF growth 3YN/A
OCF growth 5YN/A